On June 13, 2024, in FDA v. Alliance for Hippocratic Medicine, the US Supreme Court unanimously reversed a lower court decision suspending the Food and Drug Administration’s approval of mifepristone, a medication used to end pregnancies in the first trimester and treat early miscarriages. The ruling allows healthcare providers to continue distributing the medication without added restrictions.
As of June 2024, 14 states have near-total bans on mifepristone. The other 36 states and Washington, DC, provide some form of legal access to the abortion medication.
